 Clinical follow-up immunogenetic studies patients eosinophilia-myalgia syndrome patients L-tryptophan-associated eosinophilia-myalgia syndrome EMS United university hospital outpatient rheumatology clinic months onset illness patient EMS L-tryptophan months survivors cohort symptoms organ systems median disorder considerable morbidity mortality chronic sequelae long-term disability sclerodermatous skin thickening sensorimotor polyneuropathy proximal myopathy severe episodic myalgias Thrombocytopenia patient HLA-class II non-significant trend association Early therapy corticosteroids development chronic manifestations